🇺🇸 FDA
Pipeline program

Placebo to Remdesivir - Saline, Remdesivir, PF-07817883 Tablet, Placebo to Ibuzatrelvir

C5091018

Phase 3 small_molecule active

Quick answer

Placebo to Remdesivir - Saline, Remdesivir, PF-07817883 Tablet, Placebo to Ibuzatrelvir for Coronavirus Disease 2019 (COVID-19) is a Phase 3 program (small_molecule) at Pfizer Ireland Pharmaceuticals Unlimited Company with 1 ClinicalTrials.gov record(s).

Program details

Company
Pfizer Ireland Pharmaceuticals Unlimited Company
Indication
Coronavirus Disease 2019 (COVID-19)
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials